Has Heather Reed received payments from drug or device companies?

Yes. Drug and device makers reported $4,095 in general payments to Heather Reed across 178 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heather Reed did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heather Reed come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heather Reed

Physician Assistant · New Braunfels, TXNPI 1053158261

Payments from drug & device makers

$4,095in general payments, 2019–2025

Across 178 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corcept Therapeutics$566
Novo Nordisk$541
AbbVie$337
Phathom Pharmaceuticals, Inc.$300
Lilly USA, LLC$279
Xeris Pharmaceuticals, Inc.$233
plus $2K from 23 others

What the payments were for

Food & beverage$4,084100%
Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corcept Therapeutics	25	$566
Novo Nordisk	18	$541
AbbVie	27	$337
Phathom Pharmaceuticals, Inc.	4	$300
Lilly USA, LLC	13	$279
Xeris Pharmaceuticals, Inc.	13	$233
Pfizer	11	$189
Bausch Health US, LLC	9	$187
Madrigal Pharmaceuticals	2	$187
GSK	6	$173
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$137
Aerin Medical Inc.	1	$135
Axsome Therapeutics, Inc.	4	$87
Insulet Corporation	4	$81
Novartis	4	$75
Recordati_rare_diseases_inc.	4	$70
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$67
Exact Sciences	3	$56
Otsuka America Pharmaceutical, Inc.	3	$55
Azurity Pharmaceuticals, Inc.	3	$54
Dexcom, Inc.	3	$52
Averitas Pharma Inc.	2	$46
Esperion Therapeutics, Inc.	2	$41
Mannkind Corporation	2	$39
Soleno Therapeutics, Inc.	1	$29
Astellas Pharma US Inc	1	$23
Neurocrine Biosciences, Inc.	1	$23
Amneal Pharmaceuticals LLC	1	$17
AstraZeneca	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,095 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	17	$70
Azithromycin	15	$40

Paid to pharmacies, not to this prescriber.

Other physician assistant in New Braunfels

Cynthia TrickettDallas$1.3M
Kristine KuceraMelissa$797K
Selina SantosAustin$543K
Matthew BrunoMcKinney$538K
Anthony DerenciusSan Antonio$507K
Brooke HodnickSouthlake$479K
Holly GloverArlington$418K
Kirk GautierAthens$416K
Jaime RomanPlano$338K
Michael WhiteDallas$276K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →